Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)

Mazzawi,Tarek; El-Salhy,Magdy

doi:10.3892/ijmm.2017.3096

Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)

Authors:
- Tarek Mazzawi
- Magdy El-Salhy
View Affiliations

Affiliations: Division of Gastroenterology, Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway
Published online on: August 11, 2017 https://doi.org/10.3892/ijmm.2017.3096
Pages: 943-952
Copyright: © Mazzawi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal (GI) disorder that is characterized by a combination of abdominal pain or discomfort, bloating and alterations in bowel movements. This review presents recent developments concerning the roles of diet and GI endocrine cells in the pathophysiology of IBS and of individual dietary guidance in the management of IBS. Patients with IBS typically report that food aggravates their IBS symptoms. The interactions between specific types of foodstuffs rich in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and GI endocrine cells induce changes in cell densities. Providing individual dietary guidance about a low FODMAP intake, high soluble‑fiber intake, and changing the proportions of protein, fat and carbohydrates helps to reduce the symptoms experienced by patients with IBS and to improve their quality of life. These improvements are due to restoring the densities of the GI endocrine cells back to normal. The reported observations emphasize the role of GI endocrine cells in the pathophysiology of IBS and support the provision of dietary guidance as a first-line treatment for managing IBS.

View Figures

View References

1	Thompson WG: A world view of IBS. Irritable Bowel Syndrome: Diagnosis and Treatment. Camilleri M and Spiller RC: WB Saunders; Edinburgh: pp. 17–26. 2002
2	El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Irritable Bowel Syndrome. Nova Science Publishers; New York, NY: 2012
3	Camilleri M, Heading RC and Thompson WG: Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 16:1407–1430. 2002. View Article : Google Scholar : PubMed/NCBI
4	El-Salhy M: Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 18:5151–5163. 2012.PubMed/NCBI
5	Kay L, Jørgensen T and Jensen KH: The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med. 236:23–30. 1994. View Article : Google Scholar : PubMed/NCBI
6	Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al: U.S. householder survey of functional gastro-intestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 38:1569–1580. 1993. View Article : Google Scholar : PubMed/NCBI
7	Kennedy TM, Jones RH, Hungin AP, O'flanagan H and Kelly P: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 43:770–774. 1998. View Article : Google Scholar : PubMed/NCBI
8	Everhart JE and Renault PF: Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 100:998–1005. 1991. View Article : Google Scholar : PubMed/NCBI
9	Hungin AP, Whorwell PJ, Tack J and Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 17:643–650. 2003. View Article : Google Scholar : PubMed/NCBI
10	O'Keefe EA, Talley NJ, Zinsmeister AR and Jacobsen SJ: Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci. 50:M184–M189. 1995. View Article : Google Scholar : PubMed/NCBI
11	Gralnek IM, Hays RD, Kilbourne AM, Chang L and Mayer EA: Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol. 38:782–789. 2004. View Article : Google Scholar : PubMed/NCBI
12	Thompson WG, Heaton KW, Smyth GT and Smyth C: Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut. 46:78–82. 2000. View Article : Google Scholar
13	El-Salhy M, Ostgaard H, Gundersen D, Hatlebakk JG and Hausken T: The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). Int J Mol Med. 29:723–731. 2012.PubMed/NCBI
14	Mitchell CM and Drossman DA: Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 92:1282–1284. 1987. View Article : Google Scholar : PubMed/NCBI
15	Schuster MM: Defining and diagnosing irritable bowel syndrome. Am J Manag Care. 7(Suppl 8): S246–S251. 2001.PubMed/NCBI
16	El-Salhy M, Hatlebakk JG, Gilja OH and Hausken T: Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 8:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
17	Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR and Evans RW: Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 109:1736–1741. 1995. View Article : Google Scholar : PubMed/NCBI
18	Thompson WG and Heaton KW: Functional bowel disorders in apparently healthy people. Gastroenterology. 79:283–288. 1980.PubMed/NCBI
19	Bordie AK: Functional disorders of the colon. J Indian Med Assoc. 58:451–456. 1972.PubMed/NCBI
20	Jones R and Lydeard S: Irritable bowel syndrome in the general population. BMJ. 304:87–90. 1992. View Article : Google Scholar : PubMed/NCBI
21	Harvey RF, Salih SY and Read AE: Organic and functional disorders in 2000 gastroenterology outpatients. Lancet. 1:632–634. 1983. View Article : Google Scholar : PubMed/NCBI
22	Wilson S, Roberts L, Roalfe A, Bridge P and Singh S: Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract. 54:495–502. 2004.PubMed/NCBI
23	Thompson WG, Irvine EJ, Pare P, Ferrazzi S and Rance L: Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 47:225–235. 2002. View Article : Google Scholar : PubMed/NCBI
24	Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL and Melton LJ III: A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol. 95:2816–2824. 2000. View Article : Google Scholar : PubMed/NCBI
25	Boyce PM, Koloski NA and Talley NJ: Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol. 95:3176–3183. 2000. View Article : Google Scholar : PubMed/NCBI
26	Abdulmajeed A, Rabab MA, Sliem HA and Hebatallah NE: Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J. 9:52011.PubMed/NCBI
27	Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, Banka NH, Bose K, Bohidar NP, Chakravartty K, et al: Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 27:22–28. 2008.PubMed/NCBI
28	Makharia GK, Verma AK, Amarchand R, Goswami A, Singh P, Agnihotri A, Suhail F and Krishnan A: Prevalence of irritable bowel syndrome: a community based study from northern India. J Neurogastroenterol Motil. 17:82–87. 2011. View Article : Google Scholar : PubMed/NCBI
29	Liu J and Hou X: A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China. J Gastroenterol Hepatol. 26(Suppl 3): 88–93. 2011. View Article : Google Scholar : PubMed/NCBI
30	Rasmussen S, Jensen TH, Henriksen SL, Haastrup PF, Larsen PV, Søndergaard J and Jarbøl DE: Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scand J Gastroenterol. 50:162–169. 2015. View Article : Google Scholar
31	Kjellström L, Molinder H, Agréus L, Nyhlin H, Talley NJ and Andreasson A: A randomly selected population sample undergoing colonoscopy: prevalence of the irritable bowel syndrome and the impact of selection factors. Eur J Gastroenterol Hepatol. 26:268–275. 2014. View Article : Google Scholar : PubMed/NCBI
32	Vandvik PO, Lydersen S and Farup PG: Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 41:650–656. 2006. View Article : Google Scholar : PubMed/NCBI
33	Breckan RK, Asfeldt AM, Straume B, Florholmen J and Paulssen EJ: Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scand J Gastroenterol. 47:1274–1282. 2012. View Article : Google Scholar : PubMed/NCBI
34	Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F and Spiller RC: Functional bowel disorders. Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
35	El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG and Hausken T: Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 20:384–400. 2014. View Article : Google Scholar : PubMed/NCBI
36	Hahn BA, Yan S and Strassels S: Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 60:77–81. 1999. View Article : Google Scholar : PubMed/NCBI
37	Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, et al: Clinical Services Committee of The British Society of Gastroenterology: Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 56:1770–1798. 2007. View Article : Google Scholar : PubMed/NCBI
38	Tillisch K, Labus JS, Naliboff BD, Bolus R, Shetzline M, Mayer EA and Chang L: Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome. Am J Gastroenterol. 100:896–904. 2005. View Article : Google Scholar : PubMed/NCBI
39	Drossman DA: Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. Feb 19–2016.Epub ahead of print. View Article : Google Scholar
40	Harvey RF, Mauad EC and Brown AM: Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1:963–965. 1987. View Article : Google Scholar : PubMed/NCBI
41	García Rodríguez LA, Ruigómez A, Wallander MA, Johansson S and Olbe L: Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 35:306–311. 2000. View Article : Google Scholar : PubMed/NCBI
42	Nørgaard M, Farkas DK, Pedersen L, Erichsen R, de la Cour ZD, Gregersen H and Sørensen HT: Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer. 104:1202–1206. 2011. View Article : Google Scholar : PubMed/NCBI
43	Whitehead WE, Burnett CK, Cook EW III and Taub E: Impact of irritable bowel syndrome on quality of life. Dig Dis Sci. 41:2248–2253. 1996. View Article : Google Scholar : PubMed/NCBI
44	Schmulson MRG and Kershenobich D: Los pacientes con trastornos funcionales digestivos (TFD) tienen major compromiso de la calidad de vida (CV) evaluadas por el SF-36 comparados con pacientes con hepatitis C y pancreatitis cronica. Rev Gastroenterol Mex. 65(Suppl): 50–51. 2000.In Spanish.
45	Martin R, Barron JJ and Zacker C: Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care. 7(Suppl 8): S268–S275. 2001.PubMed/NCBI
46	Spiegel BM: The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 11:265–269. 2009. View Article : Google Scholar : PubMed/NCBI
47	American Gastroenterological Association: The burden of gastrointestinal diseases. Bethesda, MD: 2001
48	Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A and Rubin R: The burden of selected digestive diseases in the United States. Gastroenterology. 122:1500–1511. 2002. View Article : Google Scholar : PubMed/NCBI
49	Li FX, Patten SB, Hilsden RJ and Sutherland LR: Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta. Can J Gastroenterol. 17:259–263. 2003. View Article : Google Scholar : PubMed/NCBI
50	Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ and Müller-Lissner SA: Functional bowel disorders and functional abdominal pain. Gut. 45(Suppl 2): II43–II47. 1999. View Article : Google Scholar : PubMed/NCBI
51	Spanier JA, Howden CW and Jones MP: A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med. 163:265–274. 2003. View Article : Google Scholar : PubMed/NCBI
52	Ostgaard H, Hausken T, Gundersen D and El-Salhy M: Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep. 5:1382–1390. 2012.PubMed/NCBI
53	Canavan C, West J and Card T: Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 40:1023–1034. 2014. View Article : Google Scholar : PubMed/NCBI
54	Saito YA: The role of genetics in IBS. Gastroenterol Clin North Am. 40:45–67. 2011. View Article : Google Scholar : PubMed/NCBI
55	Lee YJ and Park KS: Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol. 20:2456–2469. 2014. View Article : Google Scholar : PubMed/NCBI
56	Grover M, Camilleri M, Smith K, Linden DR and Farrugia G: On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil. 26:156–167. 2014. View Article : Google Scholar : PubMed/NCBI
57	Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, Oshima N, Moriyama I, Yuki T, Kawashima K, et al: Pathogenesis of irritable bowel syndrome - review regarding associated infection and immune activation. Digestion. 87:204–211. 2013. View Article : Google Scholar
58	Lin HC: Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA. 292:852–858. 2004. View Article : Google Scholar : PubMed/NCBI
59	Hong SN and Rhee PL: Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol. 20:2470–2481. 2014. View Article : Google Scholar : PubMed/NCBI
60	Balsari A, Ceccarelli A, Dubini F, Fesce E and Poli G: The fecal microbial population in the irritable bowel syndrome. Microbiologica. 5:185–194. 1982.PubMed/NCBI
61	El-Salhy M: Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (Review). Int J Mol Med. 24:727–732. 2009. View Article : Google Scholar : PubMed/NCBI
62	El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG and Hausken T: Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol. 20:2383–2391. 2014. View Article : Google Scholar : PubMed/NCBI
63	El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH and Hausken T: Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept. 188:60–65. 2014. View Article : Google Scholar
64	El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T: Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome. Mol Med Rep. 7:1081–1085. 2013. View Article : Google Scholar : PubMed/NCBI
65	El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar :
66	El-Salhy M, Lomholt-Beck B and Hausken T: Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 45:1435–1439. 2010. View Article : Google Scholar : PubMed/NCBI
67	El-Salhy M, Mazzawi T, Gundersen D and Hausken T: Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep. 6:1223–1225. 2012. View Article : Google Scholar : PubMed/NCBI
68	El-Salhy M and Rauma J: Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes. Mol Med Rep. 2:893–896. 2009. View Article : Google Scholar : PubMed/NCBI
69	El-Salhy M, Vaali K, Dizdar V and Hausken T: Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci. 55:3508–3513. 2010. View Article : Google Scholar : PubMed/NCBI
70	El-Salhy M, Wendelbo IH and Gundersen D: Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Rep. 7:1241–1244. 2013. View Article : Google Scholar : PubMed/NCBI
71	Simrén M, Månsson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U and Björnsson ES: Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 63:108–115. 2001. View Article : Google Scholar : PubMed/NCBI
72	Monsbakken KW, Vandvik PO and Farup PG: Perceived food intolerance in subjects with irritable bowel syndrome - etiology, prevalence and consequences. Eur J Clin Nutr. 60:667–672. 2006. View Article : Google Scholar : PubMed/NCBI
73	Dainese R, Galliani EA, De Lazzari F, Di Leo V and Naccarato R: Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol. 94:1892–1897. 1999. View Article : Google Scholar : PubMed/NCBI
74	Heizer WD, Southern S and McGovern S: The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review. J Am Diet Assoc. 109:1204–1214. 2009. View Article : Google Scholar : PubMed/NCBI
75	Gibson PR and Shepherd SJ: Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 25:252–258. 2010. View Article : Google Scholar : PubMed/NCBI
76	Gibson PR: Food intolerance in functional bowel disorders. J Gastroenterol Hepatol. 26(Suppl 3): 128–131. 2011. View Article : Google Scholar : PubMed/NCBI
77	Barrett JS and Gibson PR: Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol. 5:261–268. 2012. View Article : Google Scholar : PubMed/NCBI
78	de Roest RH, Dobbs BR, Chapman BA, Batman B, O'Brien LA, Leeper JA, Hebblethwaite CR and Gearry RB: The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract. 67:895–903. 2013. View Article : Google Scholar : PubMed/NCBI
79	Nanda R, James R, Smith H, Dudley CR and Jewell DP: Food intolerance and the irritable bowel syndrome. Gut. 30:1099–1104. 1989. View Article : Google Scholar : PubMed/NCBI
80	Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, Gibson PR and Muir JG: Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet. 24:154–176. 2011. View Article : Google Scholar : PubMed/NCBI
81	Muir JG, Rose R, Rosella O, Liels K, Barrett JS, Shepherd SJ and Gibson PR: Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem. 57:554–565. 2009. View Article : Google Scholar : PubMed/NCBI
82	Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS and Gibson PR: Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem. 55:6619–6627. 2007. View Article : Google Scholar : PubMed/NCBI
83	Gibson GR, Probert HM, Loo JV, Rastall RA and Roberfroid MB: Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 17:259–275. 2004. View Article : Google Scholar : PubMed/NCBI
84	Gibson GR, McCartney AL and Rastall RA: Prebiotics and resistance to gastrointestinal infections. Br J Nutr. 93(Suppl 1): 31–34. 2005. View Article : Google Scholar
85	Szajewska H, Ruszczyński M and Radzikowski A: Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 149:367–372. 2006. View Article : Google Scholar : PubMed/NCBI
86	Cashman K: Prebiotics and calcium bioavailability. Curr Issues Intest Microbiol. 4:21–32. 2003.PubMed/NCBI
87	Kleessen B and Blaut M: Modulation of gut mucosal biofilms. Br J Nutr. 93(Suppl 1): 35–40. 2005. View Article : Google Scholar
88	Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, et al: Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 85:488–96. 2007.PubMed/NCBI
89	Feinle-Bisset C and Azpiroz F: Dietary lipids and functional gastrointestinal disorders. Am J Gastroenterol. 108:737–747. 2013. View Article : Google Scholar : PubMed/NCBI
90	Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR and Muir JG: Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol. 25:1366–1373. 2010. View Article : Google Scholar : PubMed/NCBI
91	Shepherd SJ and Gibson PR: Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 106:1631–1639. 2006. View Article : Google Scholar : PubMed/NCBI
92	Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, Haines ML, Shepherd SJ and Gibson PR: Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 31:874–882. 2010.PubMed/NCBI
93	El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG and Hausken T: Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med. 34:363–371. 2014. View Article : Google Scholar : PubMed/NCBI
94	Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J and Palva A: The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 133:24–33. 2007. View Article : Google Scholar : PubMed/NCBI
95	Si JM, Yu YC, Fan YJ and Chen SJ: Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 10:1802–1805. 2004. View Article : Google Scholar : PubMed/NCBI
96	Talukder S: Effect of dietary fiber on properties and acceptance of meat products: a review. Crit Rev Food Sci Nutr. 55:1005–1011. 2015. View Article : Google Scholar
97	Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW and de Wit NJ: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 19:245–251. 2004. View Article : Google Scholar : PubMed/NCBI
98	Quartero AO, Meineche-Schmidt V, Muris J, Rubin G and de Wit N: Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 18:CD0034602005.
99	Akehurst R and Kaltenthaler E: Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 48:272–282. 2001. View Article : Google Scholar : PubMed/NCBI
100	Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM and Quigley EM: Task Force on the Management of Functional Bowel Disorders American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 109(Suppl 1): S2–S26. 2014. View Article : Google Scholar
101	Parr NJ, Grime JS, Baxter JN, Critchley M and Mackie CR: Small bowel resistances and the gastroduodenal brake. Gut. 28:950–954. 1987. View Article : Google Scholar : PubMed/NCBI
102	White CM, Poxon V and Alexander-Williams J: Effects of nutrient liquids on human gastroduodenal motor activity. Gut. 24:1109–1116. 1983. View Article : Google Scholar : PubMed/NCBI
103	Vidon N, Chaussade S, Merite F, Huchet B, Franchisseur C and Bernier JJ: Inhibitory effect of high caloric load of carbohydrates or lipids on human pancreatic secretions: a jejunal brake. Am J Clin Nutr. 50:231–236. 1989.PubMed/NCBI
104	Vidon N, Pfeiffer A, Franchisseur C, Bovet M, Rongier M and Bernier JJ: Effect of different caloric loads in human jejunum on meal-stimulated and nonstimulated biliopancreatic secretion. Am J Clin Nutr. 47:400–405. 1988.PubMed/NCBI
105	Cunningham KM, Daly J, Horowitz M and Read NW: Gastrointestinal adaptation to diets of differing fat composition in human volunteers. Gut. 32:483–486. 1991. View Article : Google Scholar : PubMed/NCBI
106	Boyd KA, O'Donovan DG, Doran S, Wishart J, Chapman IM, Horowitz M and Feinle C: High-fat diet effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men. Am J Physiol Gastrointest Liver Physiol. 284:G188–G196. 2003. View Article : Google Scholar
107	Lin HC, Zhao XT and Wang L: Jejunal brake: inhibition of intestinal transit by fat in the proximal small intestine. Dig Dis Sci. 41:326–329. 1996. View Article : Google Scholar : PubMed/NCBI
108	Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ and Silk DB: The ileal brake - inhibition of jejunal motility after ileal fat perfusion in man. Gut. 25:365–374. 1984. View Article : Google Scholar : PubMed/NCBI
109	Salvioli B, Serra J, Azpiroz F and Malagelada JR: Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol. 101:1853–1857. 2006. View Article : Google Scholar : PubMed/NCBI
110	Simrén M, Abrahamsson H and Björnsson ES: Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors. Clin Gastroenterol Hepatol. 5:201–208. 2007. View Article : Google Scholar
111	Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, Pierdomenico SD, Cuccurullo F and Neri M: Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol. 100:383–389. 2005. View Article : Google Scholar : PubMed/NCBI
112	Gibson PR, Barrett JS and Muir JG: Functional bowel symptoms and diet. Intern Med J. 43:1067–1074. 2013. View Article : Google Scholar : PubMed/NCBI
113	Windey K, De Preter V and Verbeke K: Relevance of protein fermentation to gut health. Mol Nutr Food Res. 56:184–196. 2012. View Article : Google Scholar
114	Smith EA and Macfarlane GT: Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe. 3:327–337. 1997. View Article : Google Scholar
115	Blachier F, Mariotti F, Huneau JF and Tomé D: Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids. 33:547–562. 2007. View Article : Google Scholar
116	Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, et al: A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 144:903–911. 2013. View Article : Google Scholar : PubMed/NCBI
117	Talley NJ: Dietary modification as a treatment for irritable bowel syndrome. Gastroenterol Hepatol. 8:552–554. 2012.
118	Gibson PR and Shepherd SJ: Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 107:657–667. 2012. View Article : Google Scholar : PubMed/NCBI
119	Sandström O and El-Salhy M: Ageing and endocrine cells of human duodenum. Mech Ageing Dev. 108:39–48. 1999. View Article : Google Scholar : PubMed/NCBI
120	Sternini C, Anselmi L and Rozengurt E: Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes. 15:73–78. 2008. View Article : Google Scholar : PubMed/NCBI
121	Moran GW, Leslie FC, Levison SE, Worthington J and McLaughlin JT: Enteroendocrine cells: neglected players in gastrointestinal disorders? Therap Adv Gastroenterol. 1:51–60. 2008. View Article : Google Scholar : PubMed/NCBI
122	Moran-Ramos S, Tovar AR and Torres N: Diet: friend or foe of enteroendocrine cells - how it interacts with enteroendocrine cells. Adv Nutr. 3:8–20. 2012. View Article : Google Scholar : PubMed/NCBI
123	Buffa R, Capella C, Fontana P, Usellini L and Solcia E: Types of endocrine cells in the human colon and rectum. Cell Tissue Res. 192:227–240. 1978. View Article : Google Scholar : PubMed/NCBI
124	Barker N and Clevers H: Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology. 133:1755–1760. 2007. View Article : Google Scholar : PubMed/NCBI
125	Sandstrom O and El-Salhy M: Age-related changes in neuroendocrine system of the gut. A possible role in the pathogenesis of gastrointestinal disorders in the elderly. Minireview based on a doctoral thesis. Ups J Med Sci. 106:81–97. 2001.
126	Barker N, van de Wetering M and Clevers H: The intestinal stem cell. Genes Dev. 22:1856–1864. 2008. View Article : Google Scholar : PubMed/NCBI
127	May CL and Kaestner KH: Gut endocrine cell development. Mol Cell Endocrinol. 323:70–75. 2010. View Article : Google Scholar :
128	Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ and Clevers H: Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 19:379–383. 1998. View Article : Google Scholar : PubMed/NCBI
129	Cheng H and Leblond CP: Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat. 141:537–561. 1974. View Article : Google Scholar : PubMed/NCBI
130	Fontaine J, Le Lièvre C and Le Douarin NM: What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? Gen Comp Endocrinol. 33:394–404. 1977. View Article : Google Scholar : PubMed/NCBI
131	Le Douarin NM and Teillet MA: The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol. 30:31–48. 1973.PubMed/NCBI
132	Rawdon BB and Andrew A: Origin and differentiation of gut endocrine cells. Histol Histopathol. 8:567–580. 1993.PubMed/NCBI
133	Hoffman J, Kuhnert F, Davis CR and Kuo CJ: Wnts as essential growth factors for the adult small intestine and colon. Cell Cycle. 3:554–557. 2004. View Article : Google Scholar : PubMed/NCBI
134	Höcker M and Wiedenmann B: Molecular mechanisms of enteroendocrine differentiation. Ann N Y Acad Sci. 859:160–174. 1998. View Article : Google Scholar
135	Inokuchi H, Fujimoto S and Kawai K: Cellular kinetics of gastrointestinal mucosa, with special reference to gut endocrine cells. Arch Histol Jpn. 46:137–157. 1983. View Article : Google Scholar : PubMed/NCBI
136	Tolhurst G, Reimann F and Gribble FM: Intestinal sensing of nutrients. Handb Exp Pharmacol. 209:309–335. 2012. View Article : Google Scholar
137	Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, Havel PJ and Raybould HE: Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 302:R657–R666. 2012. View Article : Google Scholar
138	Parker HE, Reimann F and Gribble FM: Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med. 12:e12010. View Article : Google Scholar : PubMed/NCBI
139	Raybould HE: Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem. 64:349–356. 2008. View Article : Google Scholar
140	San Gabriel A, Nakamura E, Uneyama H and Torii K: Taste, visceral information and exocrine reflexes with glutamate through umami receptors. J Med Invest. 56(Suppl): 209–217. 2009. View Article : Google Scholar : PubMed/NCBI
141	Rudholm T, Wallin B, Theodorsson E, Näslund E and Hellström PM: Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats. Regul Pept. 152:8–12. 2009. View Article : Google Scholar
142	Sternini C: Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing. Am J Physiol Gastrointest Liver Physiol. 292:G457–G461. 2007. View Article : Google Scholar
143	Buchan AM: Nutrient tasting and signaling mechanisms in the gut III. Endocrine cell recognition of luminal nutrients. Am J Physiol. 277:G1103–G1107. 1999.PubMed/NCBI
144	Montero-Hadjadje M, Elias S, Chevalier L, Benard M, Tanguy Y, Turquier V, Galas L, Yon L, Malagon MM, Driouich A, et al: Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem. 284:12420–12431. 2009. View Article : Google Scholar : PubMed/NCBI
145	Shooshtarizadeh P, Zhang D, Chich JF, Gasnier C, Schneider F, Haïkel Y, Aunis D and Metz-Boutigue MH: The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept. 165:102–110. 2010. View Article : Google Scholar
146	El-Salhy M, Seim I, Chopin L, Gundersen D, Hatlebakk JG and Hausken T: Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci. 4:2783–2800. 2012.
147	Gunawardene AR, Corfe BM and Staton CA: Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol. 92:219–231. 2011. View Article : Google Scholar : PubMed/NCBI
148	El-Salhy M: The possible role of the gut neuroendocrine system in diabetes gastroenteropathy. Histol Histopathol. 17:1153–1161. 2002.PubMed/NCBI
149	Debas HT and Mulvihill SJ: Neuroendocrine design of the gut. Am J Surg. 161:243–249. 1991. View Article : Google Scholar : PubMed/NCBI
150	Goyal RK and Hirano I: The enteric nervous system. N Engl J Med. 334:1106–1115. 1996. View Article : Google Scholar : PubMed/NCBI
151	McConalogue K and Furness JB: Gastrointestinal neurotransmitters. Baillieres Clin Endocrinol Metab. 8:51–76. 1994. View Article : Google Scholar : PubMed/NCBI
152	Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ and Gibson PR: Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohn's Colitis. 3:8–14. 2009. View Article : Google Scholar
153	Halmos EP, Power VA, Shepherd SJ, Gibson PR and Muir JG: A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 146:67–75. 2014. View Article : Google Scholar
154	Shepherd SJ1, Parker FC, Muir JG and Gibson PR: Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol. 6:765–771. 2008. View Article : Google Scholar : PubMed/NCBI
155	Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM and Whelan K: Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 142:1510–1518. 2012. View Article : Google Scholar : PubMed/NCBI
156	Staudacher HM, Whelan K, Irving PM and Lomer MC: Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 24:487–495. 2011. View Article : Google Scholar : PubMed/NCBI
157	Wilder-Smith CH, Materna A, Wermelinger C and Schuler J: Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther. 37:1074–1083. 2013. View Article : Google Scholar : PubMed/NCBI
158	Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR and Muir JG: Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 64:93–100. 2015. View Article : Google Scholar
159	Hustoft TN, Hausken T, Ystad SO, Valeur J, Brokstad K, Hatlebakk JG and Lied GA: Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. 29:2017. View Article : Google Scholar
160	Böhn L, Störsrud S and Simrén M: Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol Motil. 25:23–30. 2013. View Article : Google Scholar
161	Ligaarden SC, Lydersen S and Farup PG: Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population. BMC Gastroenterol. 12:612012. View Article : Google Scholar : PubMed/NCBI
162	Williams EA, Nai X and Corfe BM: Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterol. 11:92011. View Article : Google Scholar : PubMed/NCBI
163	Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N and Drossman D: National Survey on Patient Educational Needs in IBS and Development and Validation of the Patient Educational Needs Questionnaire (PEQ): What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol. 102:1972–1982. 2007. View Article : Google Scholar : PubMed/NCBI
164	El-Salhy M and Gundersen D: Diet in irritable bowel syndrome. Nutr J. 14:362015. View Article : Google Scholar : PubMed/NCBI
165	El-Salhy M, Lillebø E, Reinemo A, Salmelid L and Hausken T: Effects of a health program comprising reassurance, diet management, probiotics administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterol Insights. 2:1–6. 2010. View Article : Google Scholar
166	Mazzawi T, Hausken T, Gundersen D and El-Salhy M: Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep. 8:845–852. 2013. View Article : Google Scholar : PubMed/NCBI
167	Roalfe AK, Roberts LM and Wilson S: Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol. 8:302008. View Article : Google Scholar : PubMed/NCBI
168	Patrick DL, Drossman DA, Frederick IO, DiCesare J and Puder KL: Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 43:400–411. 1998. View Article : Google Scholar : PubMed/NCBI
169	Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, Jia H and Bangdiwala SI: Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 95:999–1007. 2000. View Article : Google Scholar : PubMed/NCBI
170	Talley NJ, Verlinden M and Jones M: Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ther. 15:207–216. 2001. View Article : Google Scholar : PubMed/NCBI
171	Arslan G, Lind R, Olafsson S, Florvaag E and Berstad A: Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index. Dig Dis Sci. 49:680–687. 2004. View Article : Google Scholar : PubMed/NCBI
172	Mazzawi T and El-Salhy M: Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med. 12:1398–1404. 2016. View Article : Google Scholar : PubMed/NCBI
173	Mazzawi T, Gundersen D, Hausken T and El-Salhy M: Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep. 10:2322–2326. 2014. View Article : Google Scholar : PubMed/NCBI
174	Mazzawi T, Hausken T, Gundersen D and El-Salhy M: Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr. 70:175–181. 2016. View Article : Google Scholar :
175	Mazzawi T and El-Salhy M: Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med. 2017. View Article : Google Scholar
176	Deftos LJ: Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev. 12:181–187. 1991. View Article : Google Scholar : PubMed/NCBI
177	Taupenot L, Harper KL and O'Connor DT: The chromogranin-secretogranin family. N Engl J Med. 348:1134–1149. 2003. View Article : Google Scholar : PubMed/NCBI
178	Wiedenmann B and Huttner WB: Synaptophysin and chromogranins/secretogranins - widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol. 58:95–121. 1989. View Article : Google Scholar
179	Mazzawi T and El-Salhy M: Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med. 37:1247–1253. 2016. View Article : Google Scholar : PubMed/NCBI
180	Mazzawi T, Gundersen D, Hausken T and El-Salhy M: Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract. 2015:8238972015. View Article : Google Scholar : PubMed/NCBI
181	Mazzawi T, Hausken T, Gundersen D and El-Salhy M: Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. Eur J Clin Nutr. 69:519–524. 2015. View Article : Google Scholar :